Marksans Pharma informs about press release

03 Oct 2023 Evaluate
Marksans Pharma has informed that it has received final approval from US FDA for its Abbreviated New Drug Application (ANDA) for Esomeprazole Magnesium delayed-release capsule USP, 20 mg (OTC).

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

291.60 2.10 (0.73%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.